Limbal-conjunctival autograft transplantation for recurrent pterygium

To assess the usefulness of limbal-conjunctival autograft transplantation (LCAT) for the treatment of recurrent pterygium. Seventeen eyes with advanced recurrent pterygium underwent LCAT All had already been treated at least twice either by simple excision (n=15) or by conjunctival rotation autograf...

Full description

Saved in:
Bibliographic Details
Published in:European journal of ophthalmology 2002-05, Vol.12 (3), p.177-182
Main Authors: DEKARIS, I, GABRIC, N, KARAMAN, Z, MRAVICIC, I, KASTELAN, S
Format: Article
Language:English
Subjects:
Adult
Amnion - transplantation
Biological and medical sciences
Conjunctiva - transplantation
Diseases of eyelid, conjunctiva and lacrimal tracts
Epithelium, Corneal - transplantation
Female
Humans
Limbus Corneae - cytology
Male
Medical sciences
Middle Aged
Ophthalmology
Postoperative Complications
Pterygium - surgery
Recurrence
Stem Cells - cytology
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the eye and orbit
Transplantation, Autologous
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To assess the usefulness of limbal-conjunctival autograft transplantation (LCAT) for the treatment of recurrent pterygium. Seventeen eyes with advanced recurrent pterygium underwent LCAT All had already been treated at least twice either by simple excision (n=15) or by conjunctival rotation autograft (n=2). Three eyes (17.65%) had symblepharon at the time of surgery, so LCAT was combined with amniotic membrane transplantation. The autograft was taken from the supero-lateral part of the same eye and transferred to the area where the pterygium had been excised. During 6-18 months of follow-up no postoperative complications occurred. In 15 eyes (88.24%) no pterygium recurrence was recorded; recurrence occurred in two eyes (11.76%) after 8 and 5 months. In three eyes with a combined symblepharon formation, remission of both pterygium and symblepharon growth was obtained. LCAT seems to be a promising and safe procedure for recurrent pterygium.
ISSN:1120-6721
1724-6016
DOI:10.1177/112067210201200301